New weight loss injection begins human testing
NCT ID NCT06714955
Summary
This early-stage study tested a new injectable medication called BGM0504 in adults who are overweight or obese but do not have diabetes. The main goal was to check how safe the drug is, how the body processes it, and if it affects body weight. Thirty participants received either the drug or a placebo (dummy injection) to compare results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-DIABETIC OVERWEIGHT OR OBESE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pharmaron CPC, Inc
Baltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.